Zeitler, E. P., Friedman, D. J., Daubert, J. P., Al-Khatib, S. M., Solomon, S. D., Biton, Y., … Kutyifa, V. (2017). Reply: The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities. J Am Coll Cardiol, 70(16), 2097–2098. https://doi.org/10.1016/j.jacc.2017.07.795

Zeitler, Emily P., Daniel J. Friedman, James P. Daubert, Sana M. Al-Khatib, Scott D. Solomon, Yitschak Biton, Scott McNitt, Wojciech Zareba, Arthur J. Moss, and Valentina Kutyifa. “Reply: The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities.” J Am Coll Cardiol 70, no. 16 (October 17, 2017): 2097–98. https://doi.org/10.1016/j.jacc.2017.07.795.

Zeitler EP, Friedman DJ, Daubert JP, Al-Khatib SM, Solomon SD, Biton Y, et al. Reply: The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities. J Am Coll Cardiol. 2017 Oct 17;70(16):2097–8.

Zeitler, Emily P., et al. “Reply: The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities.” J Am Coll Cardiol, vol. 70, no. 16, Oct. 2017, pp. 2097–98. Pubmed, doi:10.1016/j.jacc.2017.07.795.

Zeitler EP, Friedman DJ, Daubert JP, Al-Khatib SM, Solomon SD, Biton Y, McNitt S, Zareba W, Moss AJ, Kutyifa V. Reply: The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities. J Am Coll Cardiol. 2017 Oct 17;70(16):2097–2098.